VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
73 hedge funds and large institutions have $1.81B invested in Verve Therapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $2.25B → $1.81B (-$437M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
73
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$57.2M | |
| 2 | +$33.8M | |
| 3 | +$29.2M | |
| 4 |
BlackRock
New York
|
+$19.5M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.4M |
Top Sellers
| 1 | -$41.3M | |
| 2 | -$24.7M | |
| 3 | -$14.8M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$11.4M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$9.08M |